Automation In Pharmaceutical Manufacturing Market
Automation in Pharmaceutical Manufacturing Market Forecasts to 2032 – Global Analysis By Component (Hardware, Software, and Services), Mode of Automation (Semi-Automatic Systems, and Fully Automatic Systems), Application, End User and By Geography
According to Stratistics MRC, the Global Automation in Pharmaceutical Manufacturing Market is accounted for $13.5 billion in 2025 and is expected to reach $28.7 billion by 2032 growing at a CAGR of 11.3% during the forecast period. Automation in pharmaceutical manufacturing involves integrating robotics, process control systems, and data analytics to streamline production of medicines, vaccines, and biologics. It enhances precision, consistency, and regulatory compliance by automating formulation, filling, packaging, and quality control. Automation reduces human intervention, minimizing contamination risks and operational errors. It accelerates production cycles while ensuring high product quality. The market grows due to increasing demand for pharmaceuticals, regulatory scrutiny, and the need for scalable, efficient production methods amid rising global health challenges.
Market Dynamics:
Driver:
Increasing demand for efficient drug production
The industry faces immense pressure to reduce time-to-market for new therapies while managing complex production workflows. Automation directly addresses this by enhancing production line throughput, minimizing human error, and ensuring batch-to-batch consistency. Furthermore, it enables manufacturers to optimize resource utilization and lower long-term operational costs. This relentless pursuit of efficiency, driven by competitive and economic pressures, is a fundamental catalyst for investing in automated systems, from robotic process automation to integrated control systems.
Restraint:
High investment in automation equipment
A significant barrier to market entry and expansion is the substantial capital expenditure required for automation infrastructure. This includes not only the initial outlay for sophisticated robotics, manufacturing execution systems (MES), and specialized hardware but also the ancillary costs for system integration, validation, and employee training. Moreover, the total cost of ownership presents a considerable financial challenge, particularly for small and mid-sized enterprises (SMEs). This high investment threshold can delay ROI calculations and necessitates long-term strategic planning, thereby restraining widespread adoption across all tiers of pharmaceutical manufacturers.
Opportunity:
Expansion of biopharmaceutical production
The rapid growth of the biopharmaceutical sector, encompassing biologics, monoclonal antibodies, and cell and gene therapies, presents a substantial opportunity for automation. These complex products require stringent environmental controls, precise process parameter management, and aseptic processing conditions that are ideally managed by automated and closed systems. Automation ensures the high fidelity and reproducibility necessary for these sensitive processes. Additionally, the scalability challenges inherent in bioproduction can be effectively mitigated through flexible and modular automation solutions, opening a new and high-value market segment for automation vendors.
Threat:
Cybersecurity threats in connected systems
As pharmaceutical manufacturing embraces Industry 4.0, the convergence of operational technology (OT) with information technology (IT) creates vulnerabilities to cyber-attacks. Connected automation systems, while efficient, are potential targets for breaches that could lead to intellectual property theft, operational shutdown, or catastrophic manipulation of process parameters compromising drug safety and efficacy. A successful attack not only poses a direct threat to patient health but also risks severe regulatory non-compliance and reputational damage. Consequently, the evolving sophistication of cyber threats remains a critical concern for the industry's digital transformation.
Covid-19 Impact:
The COVID-19 pandemic acted as a profound catalyst for the pharmaceutical automation market. It exposed critical vulnerabilities in global supply chains and highlighted the urgent need for agile and resilient manufacturing capabilities. The unprecedented demand for vaccines and therapeutics accelerated the adoption of automation to rapidly scale up production while maintaining social distancing protocols in facilities. This crisis underscored the value of automated systems in ensuring business continuity, thereby compelling many manufacturers to fast-track their digitalization and automation strategies to future-proof their operations against similar disruptions.
The hardware segment is expected to be the largest during the forecast period
The hardware segment is expected to account for the largest market share during the forecast period due to its fundamental role as the physical backbone of any automation setup. This segment includes essential components such as robotics arms, automated workcells, sensors, controllers, and assembly lines. These tangible assets require significant capital investment and are the primary enablers of automated processes on the factory floor. The continued necessity for these core components to establish initial automation capabilities, coupled with their high cost relative to software and services, solidifies hardware's dominant position in the overall market revenue.
The quality control and regulatory compliance segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the quality control and regulatory compliance segment is predicted to witness the highest growth rate. This is driven by the pharmaceutical industry's non-negotiable requirement to adhere to stringent Good Manufacturing Practice (GMP) guidelines set by agencies like the FDA and EMA. Automation in this segment, through technologies like machine vision for inspection and automated sampling systems, drastically reduces human error and provides robust, data-rich audit trails. Moreover, the increasing complexity of drug products makes manual quality checks insufficient, thereby fueling the demand for advanced, automated compliance solutions to ensure patient safety and streamline regulatory approvals.
Region with largest share:
During the forecast period, the North America region is expected to hold the largest market share. This dominance is attributed to the presence of a well-established pharmaceutical industry, a high concentration of leading market players, and early technological adoption. Furthermore, the stringent regulatory framework enforced by the U.S. FDA compelling manufacturers to implement advanced processes for quality assurance acts as a key driver. The region's robust financial capacity to invest in high-cost automation technologies and a strong focus on researching complex biologics solidify its position as the revenue leader in this market.
Region with highest CAGR:
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. This accelerated growth is fueled by the expanding pharmaceutical manufacturing footprint in countries like India and China, which are major global hubs for API and generic drug production. Governments in the region are actively promoting industrial automation through initiatives like "Industry 4.0" and "Make in India." Additionally, increasing investments from multinational corporations seeking cost-effective production alternatives, coupled with rising domestic demand for high-quality medicines, are driving the rapid modernization and automation of manufacturing facilities across the region.
Key players in the market
Some of the key players in Automation in Pharmaceutical Manufacturing Market include Siemens, Rockwell Automation, KUKA, Becton Dickinson and Company, Capsa Healthcare, Omnicell, Baxter International, Yuyama, ScriptPro, Swisslog Healthcare, SYNTEGON, IMA Group, GEA Group, FANUC, Themis Automation, Turck, Bausch+Ströbel, and Sartorius.
Key Developments:
In July 2025, Capsa Healthcare acquired BlueBin, integrating predictive analytics and Kanban-based supply chain systems to enhance clinical supply management.
In June 2025, Pharbaco achieved GMP-EU compliance by implementing advanced automation and energy-efficient cleanroom solutions, utilizing FactoryTalk® Historian for environmental data analysis.
In February 2025, Siemens announced its Xcelerator Smart Lab Ecosystem, which revolutionizes lab and cleanroom design with modular, plug-and-play infrastructure. This solution can accelerate lab design by up to 80% while ensuring compliance with pharmaceutical standards.
In January 2025, BD and Biosero announced a collaboration to integrate robotic arms with BD's flow cytometry instruments, aiming to accelerate drug discovery and development.
Components:
• Hardware
• Software
• Services
Mode of Automations Covered:
• Semi-Automatic Systems
• Fully Automatic Systems
Applications Covered:
• Drug Discovery and Development
• Clinical Trials
• Production and Processing
• Quality Control and Regulatory Compliance
• Logistics and Inventory Management
End Users Covered:
• Pharmaceutical Companies
• Biotechnology Companies
• Contract Development & Manufacturing Organizations (CDMOs / CMOs)
• Research and Academic Institutions
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Automation in Pharmaceutical Manufacturing Market, By Component
5.1 Introduction
5.2 Hardware
5.2.1 Robots
5.2.2 Control Systems
5.2.3 Sensors and Instrumentation
5.2.4 Drives and Motors
5.2.5 Other Hardware
5.3 Software
5.3.1 Manufacturing Execution System (MES)
5.3.2 Laboratory Information Management System (LIMS)
5.3.3 Enterprise Resource Planning (ERP)
5.3.4 Distributed Control System (DCS) Software
5.3.5 Process Analytical Technology (PAT) Software
5.3.6 Plant Asset Management (PAM) Software
5.4 Services
5.4.1 Integration & Consulting Services
5.4.2 Maintenance & Support Services
6 Global Automation in Pharmaceutical Manufacturing Market, By Mode of Automation
6.1 Introduction
6.2 Semi-Automatic Systems
6.3 Fully Automatic Systems
7 Global Automation in Pharmaceutical Manufacturing Market, By Application
7.1 Introduction
7.2 Drug Discovery and Development
7.3 Clinical Trials
7.4 Production and Processing
7.4.1 Active Pharmaceutical Ingredients (API) Manufacturing
7.4.2 Formulation and Fill-Finish
7.4.3 Packaging and Labeling
7.5 Quality Control and Regulatory Compliance
7.6 Logistics and Inventory Management
8 Global Automation in Pharmaceutical Manufacturing Market, By End User
8.1 Introduction
8.2 Pharmaceutical Companies
8.3 Biotechnology Companies
8.4 Contract Development & Manufacturing Organizations (CDMOs / CMOs)
8.5 Research and Academic Institutions
9 Global Automation in Pharmaceutical Manufacturing Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Siemens
11.2 Rockwell Automation
11.3 KUKA
11.4 Becton Dickinson and Company
11.5 Capsa Healthcare
11.6 Omnicell
11.7 Baxter International
11.8 Yuyama
11.9 ScriptPro
11.10 Swisslog Healthcare
11.11 SYNTEGON
11.12 IMA Group
11.13 GEA Group
11.14 FANUC
11.15 Themis Automation
11.16 Turck
11.17 Bausch+Ströbel
11.18 Sartorius
List of Tables
1 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Region (2024-2032) ($MN)
2 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Component (2024-2032) ($MN)
3 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Hardware (2024-2032) ($MN)
4 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Robots (2024-2032) ($MN)
5 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Control Systems (2024-2032) ($MN)
6 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Sensors and Instrumentation (2024-2032) ($MN)
7 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Drives and Motors (2024-2032) ($MN)
8 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Other Hardware (2024-2032) ($MN)
9 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Software (2024-2032) ($MN)
10 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Manufacturing Execution System (MES) (2024-2032) ($MN)
11 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Laboratory Information Management System (LIMS) (2024-2032) ($MN)
12 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Enterprise Resource Planning (ERP) (2024-2032) ($MN)
13 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Distributed Control System (DCS) Software (2024-2032) ($MN)
14 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Process Analytical Technology (PAT) Software (2024-2032) ($MN)
15 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Plant Asset Management (PAM) Software (2024-2032) ($MN)
16 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Services (2024-2032) ($MN)
17 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Integration & Consulting Services (2024-2032) ($MN)
18 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Maintenance & Support Services (2024-2032) ($MN)
19 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Mode of Automation (2024-2032) ($MN)
20 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Semi-Automatic Systems (2024-2032) ($MN)
21 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Fully Automatic Systems (2024-2032) ($MN)
22 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Application (2024-2032) ($MN)
23 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Drug Discovery and Development (2024-2032) ($MN)
24 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Clinical Trials (2024-2032) ($MN)
25 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Production and Processing (2024-2032) ($MN)
26 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Active Pharmaceutical Ingredients (API) Manufacturing (2024-2032) ($MN)
27 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Formulation and Fill-Finish (2024-2032) ($MN)
28 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Packaging and Labeling (2024-2032) ($MN)
29 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Quality Control and Regulatory Compliance (2024-2032) ($MN)
30 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Logistics and Inventory Management (2024-2032) ($MN)
31 Global Automation in Pharmaceutical Manufacturing Market Outlook, By End User (2024-2032) ($MN)
32 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Pharmaceutical Companies (2024-2032) ($MN)
33 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Biotechnology Companies (2024-2032) ($MN)
34 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Contract Development & Manufacturing Organizations (CDMOs / CMOs) (2024-2032) ($MN)
35 Global Automation in Pharmaceutical Manufacturing Market Outlook, By Research and Academic Institutions (2024-2032) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
